Profil
Marshall L.
Summar is currently the Director at Phlow Corp.
and the President at Society for Inherited Metabolic Disorders.
Previously, he was the Director at The National Organization for Rare Disorders, Inc. from 2012 to 2016.
Postes actifs de Marshall L. Summar
| Sociétés | Poste | Début |
|---|---|---|
Society for Inherited Metabolic Disorders
Society for Inherited Metabolic Disorders Medical/Nursing ServicesHealth Services Researches and provides medical treatment of inherited disorders of metabolism | President | - |
Phlow Corp.
Phlow Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Marshall L. Summar
| Sociétés | Poste | Fin |
|---|---|---|
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Health Services |
Society for Inherited Metabolic Disorders
Society for Inherited Metabolic Disorders Medical/Nursing ServicesHealth Services Researches and provides medical treatment of inherited disorders of metabolism | Health Services |
Phlow Corp.
Phlow Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
















